Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Mesothelioma × Radiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Glioblastoma 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Burkitt Lymphoma 6 Breast Neoplasms 6 Rhabdomyosarcoma 5 Esophageal Squamous Cell Carcinoma 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Rectal Neoplasms 3 Medulloblastoma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Hodgkin Disease 3 Gliosarcoma 3 Brain Neoplasms 3 Vaginal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma, Embryonal 2 Prostate Adenocarcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2

Interventions

Pemetrexed 5 Nivolumab 4 Cisplatin 4 Carboplatin 4 Ipilimumab 3 durvalumab 1 atezolizumab 1 Vorinostat 1 Talc 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1 Injections 1 Cerebral Decortication 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01604005 2018-01-29

PIT

The Christie NHS Foundation Trust

Phase 3 Terminated

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡